Scientific Programme

 The Scientific Programme of  "Excellence in Oncology" comprises a number of thematic streams that include:

• Genitourinary Cancer
• Lung Cancer
• Breast Cancer
• Gastrointestinal (Colorectal) Cancer
• Gastrointestinal (Noncolorectal) Cancer
• Gynaecologic Cancer
• Central Nervous System Tumours
• Cancer Genetics
• Cancer Screening
• Supportive Care
• Novel Therapeutics
• Lymphomas
• Clinical Trials
• Cancer Policies
• Cancer Staging
• CUP
• Translational Research

Specific topics per thematic will be presented in a wide range of over 45 sessions that include lectures, plenary lectures, scientific symposia, educational symposia, debates, current issues in oncology, clinical problems in oncology and meet-the-experts seminars.

Click here for the full version of the preliminary programme.

A page-by-page version of the Preliminary Programme is also available. Click here

Click here for a searchable version of the Preliminary Programme!

Key topics

Keynote Lecture

• The multidisciplinary nature of cancer care

Lectures

• Ways to overcome resistance to endocrine therapies in breast cancer
• Intra-operative radiotherapy for breast cancer - An innovative approach for the 21st century
• State of the art in the management of testicular Germ-cell tumours
• Breast cancer screening
• Lung cancer in never smokers
• Anthracyclines should remain a component of adjuvant chemotherapy in breast cancer
• Excellence in cancer care: The role of NICE

Plenary Lectures

• Erythropoiesis-stimulating agents (ESAs) in cancer patients: Where do we stand today?
• Applying research lessons to the treatment of advanced colon cancer
• Hereditary colorectal cancer
• Standard of care in the treatment of chemotherapy induced nausea and vomiting (CINV)
• State of the art in the treatment of Hodgkin lymphoma
• State of the art in the use of biologics in the adjuvant setting in colon cancer

Debates

• Adjuvant chemotherapy in stage II colon cancer
• Intraperitoneal chemotherapy for ovarian cancer
• The challenge of prostate cancer; part I: Perspectives on screening - Prostate cancer: a unique disease with special challenges
• Adjuvant immunotherapy in malignant melanoma

Current Issues in Oncology Sessions

• New challenges in head and neck cancers (organized by ESTRO)
• The challenge of prostate cancer; part II: Optimal application of therapies for patients with localized prostate cancer
• Management of cancer pain
• Interventional radiology in cancer
• State of the art in the surgical management of colorectal liver metastases
• Glioblastoma multiforme: New vistas in treatment
• Biology and treatment of breast cancer in distinct groups of patients

Clinical Problems in Oncology

• Colon cancer
• Ovarian cancer

Scientific Symposia

• Novel therapeutic approaches in breast cancer
• Cancer vaccines – Overcoming translational dilemmas that diminish cancer vaccine efficacies
• Antiangiogenic therapeutic strategies in cancer: Large-molecule inhibitors  

Educational Symposia

• Renal cell carcinoma  
• Lung cancer: Small cell lung cancer
• Infections in cancer patients
• Design and implementation of clinical trials in oncology
• Gastric and eso-gastric junction (cardia) adenocarcinoma (organized by ESDO)
• Lung cancer: Non small cell lung cancer
• Cancer of unknown primary origin  

Meet the Expert Seminars

• The optimal duration of adjuvant endocrine treatment in breast cancer
• Gastroenteropancreatic neuroendocrine tumours
• Gastroinlestinal lymphoma
• The role of consolidation and maintenance therapies in ovarian cancer

Special Sessions
American Cancer Society (ACS) Session

• Colorectal Cancer

British Journal of Surgery (BJS) Session

• Milestone papers on rectal cancer in the BJS

European Society of Digestive Oncology (ESDO) Session

• Educational symposium on Gastric and eso-gastric junction (cardia) adenocarcinoma

European Society for Therapeutic Radiology and Oncology (ESTRO) Session

• Current issues in oncology session on New challenges in head and neck cancers

International Journal of Cancer (IJC) Sessions I & II
International Union Against Cancer (UICC) Sessions I & II

• The impact of the new lung cancer staging system on clinical practice and clinical research

• Cancer staging and prognosis in the era of personalized cancer treatment

International Phycho-Oncology Society (IPOS) Session

• Cancer and the elderly